Hypertention Diagnostics Announces Resolution of Control, Progress in M&A Discussions

Author's Avatar
Jun 08, 2020
Article's Main Image

TORONTO, ON / ACCESSWIRE / June 8, 2020 / Hypertention Diagnostics Inc.(OTCMKTS:HDII) ("Hypertension Diagnostics" or the "Company") is pleased to announce that the Company's internal control dispute has been resolved, leaving Liangjian Peng in control as the CEO and controlling shareholder of Hypertension Diagnostics. The Company is currently pursuing an M&A-driven strategy, with advanced discussions now underway.